CorMedix (CRMD) Interest Coverage Ratio Growth (1y) (2013 - 2025)
CorMedix (CRMD) Interest Coverage Ratio Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | -347.04% |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | 73.00% |
| 10 | CorMedix | 5.18 Mn | -150.02 Mn | 107.31 Mn | 120.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 120.81% |
| Sep 30, 2025 | 100.28% |
| Jun 30, 2025 | 109.04% |
| Mar 31, 2025 | 138.42% |
| Dec 31, 2024 | 95.37% |
| Sep 30, 2024 | 69.21% |
| Jun 30, 2024 | 61.65% |
| Mar 31, 2024 | 55.14% |
| Dec 31, 2023 | -5,063.87% |
| Sep 30, 2023 | -50.35% |
| Jun 30, 2023 | 89.73% |
| Mar 31, 2023 | -3,484.47% |
| Dec 31, 2022 | 96.80% |
| Sep 30, 2022 | -1,447.65% |
| Jun 30, 2022 | -111,912.64% |
| Mar 31, 2022 | -756.65% |
| Dec 31, 2021 | -26.53% |
| Sep 30, 2021 | -154.78% |
| Jun 30, 2021 | 53.67% |
| Mar 31, 2021 | 97.37% |